{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:08:15Z","timestamp":1779358095582,"version":"3.51.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R01EY035499"],"award-info":[{"award-number":["R01EY035499"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R01EY027381"],"award-info":[{"award-number":["R01EY027381"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["R21EY037082"],"award-info":[{"award-number":["R21EY037082"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09840-3","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:36:10Z","timestamp":1774496170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Resolvin D1 requires TLR2-FPR2 crosstalk for inflammation resolution and protection during ocular bacterial infection"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5517-1120","authenticated-orcid":false,"given":"Pawan Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3025-1340","authenticated-orcid":false,"given":"Sukhvinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailendra","family":"Giri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6332-6591","authenticated-orcid":false,"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"9840_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.preteyeres.2006.12.001","volume":"26","author":"M Callegan","year":"2007","unstructured":"Callegan, M. et al. Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions. Prog. Retin Eye Res. 26, 189\u2013203 (2007).","journal-title":"Prog. Retin Eye Res."},{"key":"9840_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/1469-0691.12118","volume":"19","author":"ML Durand","year":"2013","unstructured":"Durand, M. L. Endophthalmitis. Clin. Microbiol. Infect. 19, 227\u2013234 (2013).","journal-title":"Clin. Microbiol. Infect."},{"key":"9840_CR3","doi-asserted-by":"crossref","unstructured":"Cioana, M. et al. Postintravitreal injection and postcataract extraction endophthalmitis visual outcomes by organism: a systematic review and meta-analysis. Retina 44, 1608\u20131618 (2024).","DOI":"10.1097\/IAE.0000000000004143"},{"key":"9840_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/0974-9233.124084","volume":"21","author":"AM Al Mahmood","year":"2014","unstructured":"Al Mahmood, A. M., Al-Swailem, S. A. & Behrens, A. Clear corneal incision in cataract surgery. Middle East Afr. J. Ophthalmol. 21, 25\u201331 (2014).","journal-title":"Middle East Afr. J. Ophthalmol."},{"key":"9840_CR5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00417-012-1926-7","volume":"250","author":"AM Almanjoumi","year":"2012","unstructured":"Almanjoumi, A. M., Combey, A., Romanet, J. P. & Chiquet, C. 23-gauge transconjunctival sutureless vitrectomy in treatment of post-operative endophthalmitis. Graefes Arch. Clin. Exp. Ophthalmol. 250, 1367\u20131371 (2012).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"9840_CR6","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.preteyeres.2012.03.004","volume":"31","author":"A Sadaka","year":"2012","unstructured":"Sadaka, A., Durand, M. L. & Gilmore, M. S. Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection. Prog. Retin Eye Res. 31, 316\u2013331 (2012).","journal-title":"Prog. Retin Eye Res."},{"key":"9840_CR7","doi-asserted-by":"crossref","unstructured":"Coburn, P. S. et al. Disarming pore-forming toxins with biomimetic nanosponges in intraocular infections. mSphere 4, e00262-19 (2019).","DOI":"10.1128\/mSphere.00262-19"},{"key":"9840_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.05.004","volume":"73","author":"FC Miller","year":"2019","unstructured":"Miller, F. C. et al. Targets of immunomodulation in bacterial endophthalmitis. Prog. Retin Eye Res. 73, 100763 (2019).","journal-title":"Prog. Retin Eye Res."},{"key":"9840_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100277","volume":"2","author":"S Singh","year":"2021","unstructured":"Singh, S. et al. Integrative metabolomics and transcriptomics identifies itaconate as an adjunct therapy to treat ocular bacterial infection. Cell Rep. Med. 2, 100277 (2021).","journal-title":"Cell Rep. Med."},{"key":"9840_CR10","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.4049\/jimmunol.2400282","volume":"213","author":"S Singh","year":"2024","unstructured":"Singh, S. et al. Myeloid cell-specific deletion of AMPKalpha1 worsens ocular bacterial infection by skewing macrophage phenotypes. J. Immunol. 213, 1656\u20131665 (2024).","journal-title":"J. Immunol."},{"key":"9840_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan, C. N., Chiang, N. & Van Dyke, T. E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349\u2013361 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"9840_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/imm.12206","volume":"141","author":"CD Russell","year":"2014","unstructured":"Russell, C. D. & Schwarze, J. The role of pro-resolution lipid mediators in infectious disease. Immunology 141, 166\u2013173 (2014).","journal-title":"Immunology"},{"key":"9840_CR13","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1111\/febs.16266","volume":"289","author":"PM Jordan","year":"2022","unstructured":"Jordan, P. M. & Werz, O. Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections. FEBS J. 289, 4212\u20134227 (2022).","journal-title":"FEBS J."},{"key":"9840_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2174\/1570159X11311060009","volume":"11","author":"S Yoo","year":"2013","unstructured":"Yoo, S., Lim, J. Y. & Hwang, S. W. Resolvins: endogenously-generated potent painkilling substances and their therapeutic perspectives. Curr. Neuropharmacol. 11, 664\u2013676 (2013).","journal-title":"Curr. Neuropharmacol."},{"key":"9840_CR15","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20020760","volume":"196","author":"CN Serhan","year":"2002","unstructured":"Serhan, C. N. et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 1025\u20131037 (2002).","journal-title":"J. Exp. Med."},{"key":"9840_CR16","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.4049\/jimmunol.176.3.1848","volume":"176","author":"CN Serhan","year":"2006","unstructured":"Serhan, C. N. et al. Anti-inflammatory actions of neuroprotectin D1\/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176, 1848\u20131859 (2006).","journal-title":"J. Immunol."},{"key":"9840_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejphar.2015.11.001","volume":"785","author":"MG Duvall","year":"2016","unstructured":"Duvall, M. G. & Levy, B. D. DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur. J. Pharm. 785, 144\u2013155 (2016).","journal-title":"Eur. J. Pharm."},{"key":"9840_CR18","doi-asserted-by":"publisher","first-page":"6269","DOI":"10.1167\/iovs.13-12152","volume":"54","author":"NK Rajasagi","year":"2013","unstructured":"Rajasagi, N. K., Reddy, P. B., Mulik, S., Gjorstrup, P. & Rouse, B. T. Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology. Investig. Ophthalmol. Vis. Sci. 54, 6269\u20136279 (2013).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"9840_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1189\/jlb.0311145","volume":"90","author":"CD Palmer","year":"2011","unstructured":"Palmer, C. D. et al. 17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli. J. Leukoc. Biol. 90, 459\u2013470 (2011).","journal-title":"J. Leukoc. Biol."},{"key":"9840_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1084\/jem.20170681","volume":"215","author":"ML Sulciner","year":"2018","unstructured":"Sulciner, M. L. et al. Resolvins suppress tumor growth and enhance cancer therapy. J. Exp. Med. 215, 115\u2013140 (2018).","journal-title":"J. Exp. Med."},{"key":"9840_CR21","doi-asserted-by":"publisher","first-page":"43079","DOI":"10.1074\/jbc.M509796200","volume":"280","author":"A Ariel","year":"2005","unstructured":"Ariel, A. et al. The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering. J. Biol. Chem. 280, 43079\u201343086 (2005).","journal-title":"J. Biol. Chem."},{"key":"9840_CR22","doi-asserted-by":"publisher","first-page":"318621","DOI":"10.1155\/2012\/318621","volume":"2012","author":"R Settimio","year":"2012","unstructured":"Settimio, R., Clara, D. F., Franca, F., Francesca, S. & Michele, D. Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis. Mediat. Inflamm. 2012, 318621 (2012).","journal-title":"Mediat. Inflamm."},{"key":"9840_CR23","doi-asserted-by":"publisher","first-page":"e58258","DOI":"10.1371\/journal.pone.0058258","volume":"8","author":"HM Hsiao","year":"2013","unstructured":"Hsiao, H. M. et al. A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation. PLoS ONE 8, e58258 (2013).","journal-title":"PLoS ONE"},{"key":"9840_CR24","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.1073\/pnas.0402531101","volume":"101","author":"PK Mukherjee","year":"2004","unstructured":"Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N. & Bazan, N. G. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA. 101, 8491\u20138496 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9840_CR25","doi-asserted-by":"publisher","first-page":"15267","DOI":"10.1074\/jbc.M410638200","volume":"280","author":"K Gronert","year":"2005","unstructured":"Gronert, K. et al. A role for the mouse 12\/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280, 15267\u201315278 (2005).","journal-title":"J. Biol. Chem."},{"key":"9840_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.2337\/db12-0684","volume":"62","author":"Y Tang","year":"2013","unstructured":"Tang, Y. et al. Proresolution therapy for the treatment of delayed healing of diabetic wounds. Diabetes 62, 618\u2013627 (2013).","journal-title":"Diabetes"},{"key":"9840_CR27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.4049\/jimmunol.178.1.496","volume":"178","author":"BD Levy","year":"2007","unstructured":"Levy, B. D. et al. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J. Immunol. 178, 496\u2013502 (2007).","journal-title":"J. Immunol."},{"key":"9840_CR28","doi-asserted-by":"publisher","first-page":"836","DOI":"10.4049\/jimmunol.0901809","volume":"184","author":"H Seki","year":"2010","unstructured":"Seki, H. et al. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J. Immunol. 184, 836\u2013843 (2010).","journal-title":"J. Immunol."},{"key":"9840_CR29","doi-asserted-by":"publisher","first-page":"14983","DOI":"10.1073\/pnas.1206641109","volume":"109","author":"D El Kebir","year":"2012","unstructured":"El Kebir, D., Gjorstrup, P. & Filep, J. G. Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc. Natl. Acad. Sci. USA. 109, 14983\u201314988 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9840_CR30","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1096\/fj.12-219519","volume":"27","author":"T Kurihara","year":"2013","unstructured":"Kurihara, T. et al. Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J. 27, 2270\u20132281 (2013).","journal-title":"FASEB J."},{"key":"9840_CR31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/jnc.12392","volume":"127","author":"SK Orr","year":"2013","unstructured":"Orr, S. K. et al. Unesterified docosahexaenoic acid is protective in neuroinflammation. J. Neurochem. 127, 378\u2013393 (2013).","journal-title":"J. Neurochem."},{"key":"9840_CR32","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.23928","volume":"74","author":"ZZ Xu","year":"2013","unstructured":"Xu, Z. Z. et al. Neuroprotectin\/protectin D1 protects against neuropathic pain in mice after nerve trauma. Ann. Neurol. 74, 490\u2013495 (2013).","journal-title":"Ann. Neurol."},{"key":"9840_CR33","doi-asserted-by":"publisher","first-page":"6856","DOI":"10.4049\/jimmunol.171.12.6856","volume":"171","author":"CN Serhan","year":"2003","unstructured":"Serhan, C. N. et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J. Immunol. 171, 6856\u20136865 (2003).","journal-title":"J. Immunol."},{"key":"9840_CR34","doi-asserted-by":"publisher","first-page":"C673","DOI":"10.1152\/ajpcell.00242.2012","volume":"305","author":"M Mustafa","year":"2013","unstructured":"Mustafa, M. et al. Resolvin D1 protects periodontal ligament. Am. J. Physiol. Cell Physiol. 305, C673\u2013C679 (2013).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"9840_CR35","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cell.2013.02.027","volume":"153","author":"M Morita","year":"2013","unstructured":"Morita, M. et al. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 153, 112\u2013125 (2013).","journal-title":"Cell"},{"key":"9840_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2174\/1568026611109060629","volume":"11","author":"CN Serhan","year":"2011","unstructured":"Serhan, C. N., Krishnamoorthy, S., Recchiuti, A. & Chiang, N. Novel anti-inflammatory-pro-resolving mediators and their receptors. Curr. Top. Med. Chem. 11, 629\u2013647 (2011).","journal-title":"Curr. Top. Med. Chem."},{"key":"9840_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2023.106806","volume":"171","author":"Z Ahmad","year":"2024","unstructured":"Ahmad, Z. et al. Untargeted and temporal analysis of retinal lipidome in bacterial endophthalmitis. Prostaglandins Other Lipid Mediat. 171, 106806 (2024).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"9840_CR38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.scib.2024.07.049","volume":"70","author":"Q Zhang","year":"2025","unstructured":"Zhang, Q. et al. Specialized pro-resolving lipid mediators: a key player in resolving inflammation in autoimmune diseases. Sci. Bull. 70, 778\u2013794 (2025).","journal-title":"Sci. Bull."},{"key":"9840_CR39","doi-asserted-by":"publisher","first-page":"e0010322","DOI":"10.1128\/iai.00103-22","volume":"90","author":"A Kumar","year":"2022","unstructured":"Kumar, A., Singh, P. K., Ahmed, Z., Singh, S. & Kumar, A. Essential role of NLRP3 inflammasome in mediating IL-1\u03b2 production and the pathobiology of Staphylococcus aureus endophthalmitis. Infect. Immun. 90, e0010322 (2022).","journal-title":"Infect. Immun."},{"key":"9840_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1167\/tvst.10.9.26","volume":"10","author":"P Naik","year":"2021","unstructured":"Naik, P. et al. Multidrug-resistant Pseudomonas aeruginosa triggers differential inflammatory response in patients with endophthalmitis. Transl. Vis. Sci. Technol. 10, 26 (2021).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"9840_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1086\/649589","volume":"201","author":"A Kumar","year":"2010","unstructured":"Kumar, A., Singh, C. N., Glybina, I. V., Mahmoud, T. H. & Yu, F. S. Toll-like receptor 2 ligand-induced protection against bacterial endophthalmitis. J. Infect. Dis. 201, 255\u2013263 (2010).","journal-title":"J. Infect. Dis."},{"key":"9840_CR42","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1128\/AAC.00126-14","volume":"58","author":"PK Singh","year":"2014","unstructured":"Singh, P. K., Donovan, D. M. & Kumar, A. Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staphylococcus aureus endophthalmitis. Antimicrob. Agents Chemother. 58, 4621\u20134629 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"9840_CR43","doi-asserted-by":"publisher","first-page":"780648","DOI":"10.3389\/fcimb.2021.780648","volume":"11","author":"S Das","year":"2021","unstructured":"Das, S., Singh, S. & Kumar, A. Bacterial burden declines but neutrophil infiltration and ocular tissue damage persist in experimental Staphylococcus epidermidis endophthalmitis. Front. Cell. Infect. Microbiol. 11, 780648 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"9840_CR44","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1167\/iovs.14-16087","volume":"56","author":"D Talreja","year":"2015","unstructured":"Talreja, D., Singh, P. K. & Kumar, A. In vivo role of TLR2 and MyD88 signaling in eliciting innate immune responses in staphylococcal endophthalmitis. Investig. Ophthalmol. Vis. Sci. 56, 1719\u20131732 (2015).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"9840_CR45","doi-asserted-by":"publisher","first-page":"30697","DOI":"10.1074\/jbc.M115.679068","volume":"290","author":"LM Poisson","year":"2015","unstructured":"Poisson, L. M. et al. Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis. J. Biol. Chem. 290, 30697\u201330712 (2015).","journal-title":"J. Biol. Chem."},{"key":"9840_CR46","doi-asserted-by":"publisher","first-page":"e0119541","DOI":"10.1371\/journal.pone.0119541","volume":"10","author":"PK Singh","year":"2015","unstructured":"Singh, P. K. & Kumar, A. Retinal photoreceptor expresses toll-like receptors (TLRs) and elicits innate responses following TLR ligand and bacterial challenge. PLoS ONE 10, e0119541 (2015).","journal-title":"PLoS ONE"},{"key":"9840_CR47","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1128\/IAI.00149-12","volume":"80","author":"T Kochan","year":"2012","unstructured":"Kochan, T., Singla, A., Tosi, J. & Kumar, A. Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory response but enhances phagocytic activity toward Staphylococcus aureus. Infect. Immun. 80, 2076\u20132088 (2012).","journal-title":"Infect. Immun."},{"key":"9840_CR48","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan, C. N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92\u2013101 (2014).","journal-title":"Nature"},{"key":"9840_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1757-3","volume":"21","author":"H Zhang","year":"2017","unstructured":"Zhang, H. et al. The common promoter polymorphism rs11666254 downregulates FPR2\/ALX expression and increases risk of sepsis in patients with severe trauma. Crit. Care 21, 171 (2017).","journal-title":"Crit. Care"},{"key":"9840_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-33","volume":"11","author":"PK Singh","year":"2014","unstructured":"Singh, P. K., Shiha, M. J. & Kumar, A. Antibacterial responses of retinal Muller glia: production of antimicrobial peptides, oxidative burst and phagocytosis. J. Neuroinflammation 11, 33 (2014).","journal-title":"J. Neuroinflammation"},{"key":"9840_CR51","doi-asserted-by":"publisher","first-page":"7089","DOI":"10.4049\/jimmunol.1100565","volume":"186","author":"N Shamsuddin","year":"2011","unstructured":"Shamsuddin, N. & Kumar, A. TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus. J. Immunol. 186, 7089\u20137097 (2011).","journal-title":"J. Immunol."},{"key":"9840_CR52","doi-asserted-by":"publisher","first-page":"e0025222","DOI":"10.1128\/iai.00252-22","volume":"91","author":"S Singh","year":"2023","unstructured":"Singh, S., Singh, P. K. & Kumar, A. Butyrate ameliorates intraocular bacterial infection by promoting autophagy and attenuating the inflammatory response. Infect. Immun. 91, e0025222 (2023).","journal-title":"Infect. Immun."},{"key":"9840_CR53","doi-asserted-by":"publisher","first-page":"11731","DOI":"10.1523\/JNEUROSCI.1395-17.2017","volume":"37","author":"I Francos-Quijorna","year":"2017","unstructured":"Francos-Quijorna, I. et al. Maresin 1 promotes inflammatory resolution, neuroprotection, and functional neurological recovery after spinal cord injury. J. Neurosci. 37, 11731\u201311743 (2017).","journal-title":"J. Neurosci."},{"key":"9840_CR54","doi-asserted-by":"crossref","unstructured":"Kilburg-Basnyat, B. et al. Specialized pro-resolving lipid mediators regulate ozone-induced pulmonary and systemic inflammation. Toxicol Sci. 163, 466\u2013477 (2018).","DOI":"10.1093\/toxsci\/kfy040"},{"key":"9840_CR55","doi-asserted-by":"crossref","unstructured":"Fullerton, J. N., O\u2019Brien, A. J. & Gilroy, D. W. Lipid mediators in immune dysfunction after severe inflammation. Trends Immunol. 35, 12\u201321 (2014).","DOI":"10.1016\/j.it.2013.10.008"},{"key":"9840_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1126\/science.347.6217.18","volume":"347","author":"M Leslie","year":"2015","unstructured":"Leslie, M. Inflammation\u2019s stop signals. Science 347, 18\u201321 (2015).","journal-title":"Science"},{"key":"9840_CR57","doi-asserted-by":"publisher","first-page":"149381","DOI":"10.1155\/2015\/149381","volume":"2015","author":"S Rossi","year":"2015","unstructured":"Rossi, S. et al. Protection from endotoxic uveitis by intravitreal Resolvin D1: involvement of lymphocytes, miRNAs, ubiquitin-proteasome, and M1\/M2 macrophages. Mediat. Inflamm. 2015, 149381 (2015).","journal-title":"Mediat. Inflamm."},{"key":"9840_CR58","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41385-018-0089-1","volume":"12","author":"DR Saban","year":"2019","unstructured":"Saban, D. R. et al. Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model. Mucosal Immunol. 12, 145\u2013153 (2019).","journal-title":"Mucosal Immunol."},{"key":"9840_CR59","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.plefa.2005.05.009","volume":"73","author":"K Gronert","year":"2005","unstructured":"Gronert, K. Lipoxins in the eye and their role in wound healing. Prostaglandins Leukot. Ess. Fat. Acids 73, 221\u2013229 (2005).","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"key":"9840_CR60","doi-asserted-by":"crossref","unstructured":"He, J. et al. Lipoxin A4 (LXA4) reduces alkali-induced corneal inflammation and neovascularization and upregulates a repair transcriptome. Biomolecules 13, 831 (2023).","DOI":"10.3390\/biom13050831"},{"key":"9840_CR61","doi-asserted-by":"crossref","unstructured":"Wei, J. et al. A novel role for lipoxin A(4) in driving a lymph node-eye axis that controls autoimmunity to the neuroretina. Elife 9, e51102 (2020).","DOI":"10.7554\/eLife.51102"},{"key":"9840_CR62","doi-asserted-by":"crossref","unstructured":"Mursalin, M. H. et al. C-X-C chemokines influence intraocular inflammation during bacillus endophthalmitis. Investig. Ophthalmol. Vis. Sci. 62, 14 (2021).","DOI":"10.1167\/iovs.62.14.14"},{"key":"9840_CR63","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.4049\/jimmunol.1502331","volume":"196","author":"A Croasdell","year":"2016","unstructured":"Croasdell, A., Lacy, S. H., Thatcher, T. H., Sime, P. J. & Phipps, R. P. Resolvin D1 dampens pulmonary inflammation and promotes clearance of nontypeable Haemophilus influenzae. J. Immunol. 196, 2742\u20132752 (2016).","journal-title":"J. Immunol."},{"key":"9840_CR64","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/mi.2015.129","volume":"9","author":"RE Abdulnour","year":"2016","unstructured":"Abdulnour, R. E. et al. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation. Mucosal Immunol. 9, 1278\u20131287 (2016).","journal-title":"Mucosal Immunol."},{"key":"9840_CR65","doi-asserted-by":"publisher","first-page":"e85922","DOI":"10.1172\/jci.insight.85922","volume":"1","author":"LV Norling","year":"2016","unstructured":"Norling, L. V. et al. Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis. JCI Insight 1, e85922 (2016).","journal-title":"JCI Insight"},{"key":"9840_CR66","doi-asserted-by":"publisher","first-page":"e28619","DOI":"10.1371\/journal.pone.0028619","volume":"6","author":"BD Novosad","year":"2011","unstructured":"Novosad, B. D., Astley, R. A. & Callegan, M. C. Role of Toll-like receptor (TLR) 2 in experimental Bacillus cereus endophthalmitis. PLoS ONE 6, e28619 (2011).","journal-title":"PLoS ONE"},{"key":"9840_CR67","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/02713680600976925","volume":"31","author":"RT Ramadan","year":"2006","unstructured":"Ramadan, R. T., Ramirez, R., Novosad, B. D. & Callegan, M. C. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr. Eye Res. 31, 955\u2013965 (2006).","journal-title":"Curr. Eye Res."},{"key":"9840_CR68","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1167\/iovs.14-15982","volume":"56","author":"JE Lee","year":"2015","unstructured":"Lee, J. E., Sun, Y., Gjorstrup, P. & Pearlman, E. Inhibition of corneal inflammation by the resolvin E1. Invest Ophthalmol. Vis. Sci. 56, 2728\u20132736 (2015).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"9840_CR69","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ajpath.2012.01.028","volume":"180","author":"S Krishnamoorthy","year":"2012","unstructured":"Krishnamoorthy, S., Recchiuti, A., Chiang, N., Fredman, G. & Serhan, C. N. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. Am. J. Pathol. 180, 2018\u20132027 (2012).","journal-title":"Am. J. Pathol."},{"key":"9840_CR70","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1096\/fj.10-169599","volume":"25","author":"A Recchiuti","year":"2011","unstructured":"Recchiuti, A., Krishnamoorthy, S., Fredman, G., Chiang, N. & Serhan, C. N. MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. FASEB J. 25, 544\u2013560 (2011).","journal-title":"FASEB J."},{"key":"9840_CR71","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/nature08541","volume":"461","author":"M Spite","year":"2009","unstructured":"Spite, M. et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287\u20131291 (2009).","journal-title":"Nature"},{"key":"9840_CR72","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","volume":"32","author":"S Gordon","year":"2010","unstructured":"Gordon, S. & Martinez, F. O. Alternative activation of macrophages: mechanism and functions. Immunity 32, 593\u2013604 (2010).","journal-title":"Immunity"},{"key":"9840_CR73","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature11042","volume":"484","author":"N Chiang","year":"2012","unstructured":"Chiang, N. et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 484, 524\u2013528 (2012).","journal-title":"Nature"},{"key":"9840_CR74","doi-asserted-by":"publisher","first-page":"8517","DOI":"10.1073\/pnas.1200189109","volume":"109","author":"PC Norris","year":"2012","unstructured":"Norris, P. C. & Dennis, E. A. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling. Proc. Natl. Acad. Sci. USA. 109, 8517\u20138522 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9840_CR75","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/emmm.201201891","volume":"5","author":"O Koltsida","year":"2013","unstructured":"Koltsida, O. et al. Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. EMBO Mol. Med. 5, 762\u2013775 (2013).","journal-title":"EMBO Mol. Med."},{"key":"9840_CR76","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1021\/jm501051x","volume":"58","author":"O Corminboeuf","year":"2015","unstructured":"Corminboeuf, O. & Leroy, X. FPR2\/ALXR agonists and the resolution of inflammation. J. Med. Chem. 58, 537\u2013559 (2015).","journal-title":"J. Med. Chem."},{"key":"9840_CR77","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/bph.14151","volume":"175","author":"M Jannaway","year":"2018","unstructured":"Jannaway, M., Torrens, C., Warner, J. A. & Sampson, A. P. Resolvin E1, resolvin D1 and resolvin D2 inhibit constriction of rat thoracic aorta and human pulmonary artery induced by the thromboxane mimetic U46619. Br. J. Pharm. 175, 1100\u20131108 (2018).","journal-title":"Br. J. Pharm."},{"key":"9840_CR78","doi-asserted-by":"publisher","first-page":"C178","DOI":"10.1152\/ajpcell.00284.2013","volume":"306","author":"JW Nelson","year":"2014","unstructured":"Nelson, J. W. et al. ALX\/FPR2 receptor for RvD1 is expressed and functional in salivary glands. Am. J. Physiol. Cell Physiol. 306, C178\u2013C185 (2014).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"9840_CR79","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1074\/jbc.M508125200","volume":"281","author":"K Chen","year":"2006","unstructured":"Chen, K. et al. Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J. Biol. Chem. 281, 3651\u20133659 (2006).","journal-title":"J. Biol. Chem."},{"key":"9840_CR80","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1189\/jlb.0907607","volume":"83","author":"K Chen","year":"2008","unstructured":"Chen, K. et al. Cooperation between NOD2 and Toll-like receptor 2 ligands in the up-regulation of mouse mFPR2, a G-protein-coupled Abeta42 peptide receptor, in microglial cells. J. Leukoc. Biol. 83, 1467\u20131475 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"9840_CR81","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1128\/IAI.01285-07","volume":"76","author":"EA Whiston","year":"2008","unstructured":"Whiston, E. A. et al. alphaB-crystallin protects retinal tissue during Staphylococcus aureus-induced endophthalmitis. Infect. Immun. 76, 1781\u20131790 (2008).","journal-title":"Infect. Immun."},{"key":"9840_CR82","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1096\/fj.14-254383","volume":"28","author":"KR Maddipati","year":"2014","unstructured":"Maddipati, K. R. et al. Eicosanomic profiling reveals dominance of the epoxygenase pathway in human amniotic fluid at term in spontaneous labor. FASEB J. 28, 4835\u20134846 (2014).","journal-title":"FASEB J."},{"key":"9840_CR83","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.prostaglandins.2011.01.003","volume":"94","author":"KR Maddipati","year":"2011","unstructured":"Maddipati, K. R. & Zhou, S. L. Stability and analysis of eicosanoids and docosanoids in tissue culture media. Prostaglandins Other Lipid Mediat. 94, 59\u201372 (2011).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"9840_CR84","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92340","volume":"2","author":"PK Singh","year":"2017","unstructured":"Singh, P. K. et al. Zika virus infects cells lining the blood-retinal barrier and causes chorioretinal atrophy in mouse eyes. JCI Insight 2, e92340 (2017).","journal-title":"JCI Insight"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09840-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09840-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:03:41Z","timestamp":1779149021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09840-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9840"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09840-3","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"674"}}